Back

Differential Expression of α,β, and γ Protocadherin Isoforms During Differentiation, Aging, and Cancer

West, M. D.; Labat, I.; Li, J.; Sim, P.; Janus, J.; Mangelson, H.; Sullivan, S.; Liachko, I.; Labhart, P.; Craske, M.; Egan, B.; Chapman, K. B.; Malik, N. N.; Larocca, D.; Sternberg, H.

2021-03-08 developmental biology
10.1101/2021.03.07.434314 bioRxiv
Show abstract

The cadherin family of cell surface glycoproteins plays a fundamental role in cell-cell recognition, thereby participating in diverse biological process such as embryonic morphogenesis and oncogenic transformation. The subset of clustered protocadherin (PCDH) genes generated from the , {beta}, and {gamma} loci, have been widely studied for their potential role in neuronal cell-cell recognition and neurogenesis, however their broader role in normal embryonic development and cancer has not been examined in detail. We utilized human embryonic stem (hES) cells to model early human development in vitro, comparing PCDH isoform transcription in diverse types of embryonic progenitors with normal adult-derived and cancer counterparts. Embryonic progenitors express genes from the and {beta} cluster at levels comparable to that seen in the CNS, while fetal and adult-derived cells express primarily from the {gamma} cluster. Replicative senescence left fibroblasts with markedly lower expression of all isoforms. We observe that an embryonic pattern of clustered protocadherin gene expression and associated CpG island methylation is commonly associated with cancer cell lines from diverse tissue types. The differential regulation of the , {beta}, and {gamma} loci coincide with alternate regions of DNA accessibility at CTCF binding sites and lamina-associated domains and CPL expression correlated with the expression of LMNA and LMNB1. These observations support a potential role for the differential regulation of genes within the clustered protocadherin locus in selective cell-cell adhesion during embryogenesis, regeneration, cancer and aging.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Cell Death Discovery
58 papers in training set
Top 0.1%
13.0%
2
Stem Cells
31 papers in training set
Top 0.1%
12.8%
3
Scientific Reports
3612 papers in training set
Top 3%
12.0%
4
Epigenetics
50 papers in training set
Top 0.1%
6.8%
5
Stem Cell Reports
130 papers in training set
Top 0.5%
4.9%
6
iScience
1154 papers in training set
Top 3%
4.9%
50% of probability mass above
7
Oncotarget
18 papers in training set
Top 0.1%
2.1%
8
Communications Biology
993 papers in training set
Top 10%
2.1%
9
Cells
249 papers in training set
Top 2%
2.1%
10
Nature Communications
5641 papers in training set
Top 43%
1.9%
11
Clinical Epigenetics
60 papers in training set
Top 0.3%
1.9%
12
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 2%
1.9%
13
eLife
5828 papers in training set
Top 48%
1.7%
14
Epigenetics & Chromatin
42 papers in training set
Top 0.3%
1.7%
15
Developmental Dynamics
56 papers in training set
Top 0.4%
1.7%
16
Aging
75 papers in training set
Top 1%
1.4%
17
PLOS Genetics
862 papers in training set
Top 8%
1.3%
18
International Journal of Molecular Sciences
494 papers in training set
Top 11%
1.1%
19
Cell Reports
1498 papers in training set
Top 23%
1.1%
20
Life Science Alliance
285 papers in training set
Top 6%
1.0%
21
Biology Open
156 papers in training set
Top 3%
1.0%
22
Aging Cell
165 papers in training set
Top 2%
1.0%
23
The FEBS Journal
93 papers in training set
Top 2%
0.9%
24
The FASEB Journal
194 papers in training set
Top 5%
0.9%
25
BMC Genomics
406 papers in training set
Top 8%
0.9%
26
PLOS ONE
5266 papers in training set
Top 60%
0.9%
27
BMC Biology
265 papers in training set
Top 5%
0.9%
28
Nucleic Acids Research
1281 papers in training set
Top 13%
0.9%
29
Open Biology
106 papers in training set
Top 2%
0.6%
30
Molecular Cancer Research
49 papers in training set
Top 1%
0.6%